| NCT ID | NCT06876857 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Central Florida |
| Condition | Biospecimen Donation |
| Study Type | OBSERVATIONAL |
| Enrollment | 50,000 participants |
| Start Date | 2025-02-25 |
| Primary Completion | 2075-02-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50,000 participants in total. It began in 2025-02-25 with a primary completion date of 2075-02-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Millions of persons are affected by brain diseases. The CereBank will be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. Brain diseases can be inherited; developed due to diseases or aging; or can be due to trauma. The Central Florida does not have a brain biobank to meet the needs of research. Therefore, it is necessary for the University of Central Florida to establish a brain biobank.
Eligibility Criteria
Inclusion Criteria: * Be 18 years or older. * Able to provide informed consent. Persons who are unable to provide an informed consent will need a Legally Authorized Representative (LAR) to sign the informed consent. Exclusion Criteria: * minors (under age 18). * prisoners. * pregnant women.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06876857 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Biospecimen Donation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06876857 currently recruiting?
Yes, NCT06876857 is actively recruiting participants. Contact the research team at britney-ann.wray@ucf.edu for enrollment information.
Where is the NCT06876857 trial being conducted?
This trial is being conducted at Orlando, United States.
Who is sponsoring the NCT06876857 clinical trial?
NCT06876857 is sponsored by University of Central Florida. The trial plans to enroll 50,000 participants.